Underdosing in Patients With Cancer and Obesity: A Thing of the Past?
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Latest Features
LATEST ARTICLES
Universal Genetic Testing Is Far From a Reality in Patients With Ovarian Cancer
A new review points to low rates of genetic testing in patients with ovarian cancer.
Age and Race May Determine Whether Cancer Patients Access Their Electronic Health Records
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
Palliative Care in Head and Neck Cancer: One Size Doesn’t Fit All
A study found no benefit to early palliative care interventions, suggesting a one-size-fits-all approach won’t work in head and neck cancer.
Caloric Reduction Improves Outcomes for Young People With Acute Lymphoblastic Leukemia
A 10% reduction in calorie intake during the first month of treatment shows promise for augmenting chemotherapy treatment in children and adolescents with ALL.
Radical Therapy for Stage III NSCLC: Practical Advice to Consider
A comprehensive review provides clinical pearls and approaches to consider regarding chemoradiotherapy for patients with stage III non-small cell lung cancer.
Deeper Dives Into the Bone Marrow Microenvironment of Myeloma Cells Provide New Insights Into Novel Therapies and Disease Biology
The immune cells in the microenvironment can reign in myeloma cells but become suppressed and dysregulated during disease progression.
Digital Mammography Drives Higher Detection Rates of DCIS
The higher contrast of this tool is better than film-screen mammography at detecting calcifications that are key to diagnosing DCIS.
RB-RECIST Criteria May Improve Retinoblastoma Management: An Interview With Jesse L. Berry, MD
In an international, multicenter collaboration, experts modified the RECIST criteria for use as objective endpoints in clinical trials of retinoblastoma therapies.
Navigating Disruptions to Lung Cancer Treatment During the COVID-19 Pandemic
Throughout the COVID-19 pandemic, clinicians who care for patients with lung cancer have made multiple treatment approach changes for this vulnerable population.
Recommendations From FDA-AACR Workshop to Increase African American Representation in Multiple Myeloma Clinical Trials
A workshop was convened by the US Food and Drug Administration and the American Association for Cancer Research to create recommendations for trial design and later stages of drug development in multiple myeloma.
Socioeconomics Tied to Cognitive Function in Survivors of Childhood Brain Tumors
Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.
COVID-19 Vaccination and Imaging Misinterpretation: An Interview With Lacey McIntosh, DO, MPH
Oncologists and patients should be aware of the potential manifestations of the COVID-19 vaccination on imaging and the consequences this might have on disease assessment, treatment monitoring, and decision-making.
Review of Barriers to Colorectal Cancer Screening in Hard-to-Reach Populations
The COVID-19 pandemic sheds new light on existing access challenges in preventive health care.
Therapeutic Approaches to Multiple Myeloma: An Interview With Ajai Chari, MD
Ajai Chari, MD, of Mount Sinai Hospital in New York City, provides his perspective on the current state of care in multiple myeloma.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...